OpenAI is developing a “super app” for desktop that unifies ChatGPT, its browser and its Codex app, according to the Wall ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

A new technique dubbed "Zombie ZIP" helps conceal payloads in compressed files specially created to avoid detection from security solutions such as antivirus and endpoint detection and response (EDR) ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Each Friday over the summer, 7NEWS is live from a different town to show off all it has to offer! During each stop, Fred Cunningham will introduce you to the heroic first responders in your community ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues ...

Editor’s Note — March 2026: We’ve updated our story to make sure items are in stock and available, plus we added a new best overall, the Goal Zero 1500 power station, a new model we recently reviewed, ...

US biotech Generate Biomedicines (Nasdaq: GENB) raised $400 million in its initial public offering, selling 25 million shares at $16 each, the midpoint of its range. It marks the largest biotech IPO ...